Navigation Links
Favrille to Present at BIOCOM Investor Conference, Acumen BioFin Rodman & Renshaw Healthcare Conference and CIBC World Markets Healthcare Conference
Date:10/26/2007

Live Webcasts from San Diego on November 2nd and New York on November 5th

SAN DIEGO, Oct. 26 /PRNewswire-FirstCall/ -- Favrille, Inc. (Nasdaq: FVRL), a biopharmaceutical company developing patient-specific, active immunotherapies for the treatment of cancer, today announced that the Company will present at three upcoming investor conferences:

(Logo: http://www.newscom.com/cgi-bin/prnh/20031013/LAM095LOGO)

-- Richard Ghalie, M.D., Chief Medical Officer, will present at the BIOCOM

Investor Conference at 11:00 a.m. Pacific time on Friday, November 2,

2007, from the San Diego Marriott Del Mar;

-- John P. Longenecker, Ph.D., President and Chief Executive Officer, will

present at the Acumen BioFin Rodman & Renshaw Healthcare Conference at

10:35 a.m. Eastern time on Monday, November 5, 2007, from the New York

Palace Hotel; and

-- Dr. Longenecker will also present at the CIBC World Markets Healthcare

Conference at 1:20 p.m. Eastern time on Monday, November 5, 2007, from

the Waldorf-Astoria in New York.

Live webcasts of all three presentations can be accessed at http://www.favrille.com. Replays will be available approximately one hour after each presentation and archived for one month.

About Favrille, Inc.

Favrille, Inc. is a biopharmaceutical company focused on the development and commercialization of targeted immunotherapies for the treatment of cancer and other diseases of the immune system. The Company's lead product candidate, FavId, is based upon unique genetic information extracted from a patient's tumor. FavId is currently under investigation in a pivotal Phase 3 clinical trial for patients with follicular B-cell NHL and Phase 2 clinical trials in other B-cell NHL indications. The Company is developing additional appli
'/>"/>

SOURCE Favrille, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ember24/PRNewswire-FirstCall/--deCODE,genetics,Inc...icefrom,theNasdaqStockMarketthattradinginthecompan...ndaForm25-NSEwillbefiledwiththe,SecuritiesandExcha...romlistingonNasdaq,unlessthecompanyfilesanappealto...filedsuchanappeal,which,willstaythesuspensionandde...
(Date:11/24/2009)...ember24/PRNewswire-FirstCall/--deCODE,genetics,Inc...s,"firstday"motionsbytheU.S.BankruptcyCourtfortheD...tweekfiledavoluntarypetitionfor,reliefunderChapter...yCourt. , TheordersissuedbytheBankruptcyCourt...ngtheChapter11proceedings.Inparticular,the,company...
(Date:11/24/2009)...swire-Asia/--ShanghaiBiolaxyannouncedthe,ChineseSt...,investigationalnewdrugapplication(IND)foritsorali...iontotreatdiabetes.ThisIND,approvalallowsBiolaxyto...esisadisordercharacteristicofhighbloodglucoseandpo...tinseveremicro-and,macro-vasculardiseases,lossofvi...
(Date:11/24/2009)...nthasbeenmetforpatientswithadvanced-stage,orrecurr...ewswire-FirstCall/-AEternaZentarisInc.(NASDAQ: AEZ...companyfocusedonendocrinetherapyandoncology,todaya...stargetedcytotoxicpeptideconjugate,AEZS-108(former...rialcancer.Inapersonalizedhealthcareapproach,thest...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
..., Get Full-length cDNA , Ambio...V reverse transcriptase , to improve prod...e transcriptase, , <A , ...048">ArrayScript , (patent pending), pro..., cDNA than wild type RTs, and rivals even...
..., Screening with small interfering RNAs ,...d for identifying genes involved , ...the , effectiveness of two stra... siRNAs and transfection of pools of siRNAs--...eriments. The increased effectiveness of testing ,...
..., Isolate total RNA and protein from cul...ate nuclear and cytoplasmic RNA and protein from c...xtraction or alcohol precipitation , Am... based on , Ambion,s RNAqueous technology... from the same experimental sample. The kit also p...
Other Biology Technology:ArrayScript RT: Maximize Yields of Full-length cDNA 2ArrayScript RT: Maximize Yields of Full-length cDNA 3Are siRNA Pools Smart? 2Are siRNA Pools Smart? 3Are siRNA Pools Smart? 4Are siRNA Pools Smart? 5Are siRNA Pools Smart? 6Are siRNA Pools Smart? 7Are siRNA Pools Smart? 8Are siRNA Pools Smart? 9A Better Way to Isolate RNA AND Protein From the Same Sample 2A Better Way to Isolate RNA AND Protein From the Same Sample 3A Better Way to Isolate RNA AND Protein From the Same Sample 4A Better Way to Isolate RNA AND Protein From the Same Sample 5
(Date:11/24/2009)...UGE Antarctica has long held secrets of the earth...ently, there has been very little information on t...s of ice for millions of years. Now, a team of res...ve been funded to the tune of $10 million dollars ... to the bottom of things literally. These scienti...
(Date:11/23/2009)..., D.C. The community-associated strain of the dea...istant to most common antibioticsposes a far great...ng its way into hospitals, according to a study in...es . , The new threat is easily picked up in fi...d has increased the overall burden of MRSA within ...
(Date:11/23/2009)..., CT Current research suggests that a common oral... related report by Nichols et al, "Unique Lipids f... of TLR2 Ligands Capable of Enhancing Autoimmunity...ican Journal of Pathology . , Multiple sclerosis...he brain and spinal cord, affects nearly 1 in 700 ...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2New study finds MRSA on the rise in hospital outpatients 2Factors from common human bacteria may trigger multiple sclerosis 2RJR Other Tobacco Companies Go to Court to Evade Regulation by FDA 55862 1RJR Other Tobacco Companies Go to Court to Evade Regulation by FDA 55862 2Fifth Third Processing Solutions to Offer mPay Gateways Patient Payment System to Its Health Care Customers 55859 1Fifth Third Processing Solutions to Offer mPay Gateways Patient Payment System to Its Health Care Customers 55859 2Fifth Third Processing Solutions to Offer mPay Gateways Patient Payment System to Its Health Care Customers 55859 3Vinpower Digital Announces Industry 26apos 3Bs First Complete Labelflash Standalone DVD Publishing System 55857 1Vinpower Digital Announces Industry 26apos 3Bs First Complete Labelflash Standalone DVD Publishing System 55857 2Vinpower Digital Announces Industry 26apos 3Bs First Complete Labelflash Standalone DVD Publishing System 55857 3
...ng paper from Drs. Hidenori Ichijo and Hideki Nish...s new and valuable insight into the genetics of AL...own as Lou Gehrig,s disease, is a rapidly progress...neration and death of motor neuron cells. , ALS ...orldwide, affecting as roughly 25,000 Americans, w...
...rch* shows that while engineered nanomaterials can...hain from single celled organisms to higher multic...low and there was no evidence of the nanomaterials...preliminary results observed by researchers from t...(NIST) suggest that the particular nanomaterials s...
...rporation has a public relations crisis, the news ...e world. According to new research in the Journal ...vokes judgments about the person and the situation...e crisis, and [our] research suggests that the fac...ion," say authors Gerald J. Gorn, Yuwei Jiang (bot...
Other Biology News:Research measures movement of nanomaterials in simple model food chain 2
Human Antibody Array I Kit, RayBio L Series 507: RayBio Label-based from Raybiotech, Inc.
Mouse Anti-Human HVEM Cell Surface Staining Monoclonal Antibodies, Allophycocyanin Conjugated, 94801 from R&D Systems
... Osmometer for 10 L sample. Ideal for small volum...iatric, general adult, veterinary and experimental...selected values. Includes built-in printer, keypa...-keeping. Optional barcode scanner available. RS...
Rabbit Anti-Human UCP2 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Biology Products: